19-54118281-G-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PS1_ModeratePM2PP5_Moderate
The NM_015629.4(PRPF31):c.3G>A(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
PRPF31
NM_015629.4 start_lost
NM_015629.4 start_lost
Scores
8
3
3
Clinical Significance
Conservation
PhyloP100: 8.59
Genes affected
PRPF31 (HGNC:15446): (pre-mRNA processing factor 31) This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.[provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
?
Start lost variant, no new inframe start found.
PS1
?
Another start lost variant in NM_015629.4 (PRPF31) was described as [Likely_pathogenic] in ClinVar as 438044
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 19-54118281-G-A is Pathogenic according to our data. Variant chr19-54118281-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 804151.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr19-54118281-G-A is described in Lovd as [Likely_pathogenic]. Variant chr19-54118281-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRPF31 | NM_015629.4 | c.3G>A | p.Met1? | start_lost | 2/14 | ENST00000321030.9 | |
PRPF31-AS1 | XR_007067340.1 | n.1843-602C>T | intron_variant, non_coding_transcript_variant | ||||
PRPF31 | XM_006723137.5 | c.3G>A | p.Met1? | start_lost | 2/14 | ||
PRPF31 | XM_047438587.1 | c.3G>A | p.Met1? | start_lost | 2/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRPF31 | ENST00000321030.9 | c.3G>A | p.Met1? | start_lost | 2/14 | 1 | NM_015629.4 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinitis pigmentosa Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
Cadd
Uncertain
Dann
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D
PROVEAN
Uncertain
D;D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
0.0
.;B;.;.;.;.
Vest4
MutPred
Gain of catalytic residue at M1 (P = 0.0276);Gain of catalytic residue at M1 (P = 0.0276);Gain of catalytic residue at M1 (P = 0.0276);Gain of catalytic residue at M1 (P = 0.0276);Gain of catalytic residue at M1 (P = 0.0276);Gain of catalytic residue at M1 (P = 0.0276);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at